A Phase 3 Randomized Double-Blind Placebo-Controlled Study Evaluating the Safety Tolerability and Efficacy of GS-9674 in Non-Cirrhotic Subjects with Primary Sclerosing Cholangitis
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
